Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (25)

2024

  1. Characterization of Immune Cell Populations and Acid-Sensing Receptors in the Human Esophagus

    Gastroenterology Insights, Vol. 15, Núm. 3, pp. 819-834

  2. Microscopic Colitis and Celiac Disease: Sharing More than a Diagnostic Overlap

    Nutrients, Vol. 16, Núm. 14

2023

  1. Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa: Implications for Irritable Bowel Syndrome

    Cells, Vol. 12, Núm. 3

  2. Acute psychological stress increases paracellular permeability and modulates immune activity in rectal mucosa of healthy volunteers

    United European Gastroenterology Journal, Vol. 11, Núm. 1, pp. 31-41

  3. Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants

    Journal of Translational Medicine, Vol. 21, Núm. 1

  4. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery

    Frontiers in Immunology, Vol. 14

2022

  1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

2021

  1. Present and Future Therapeutic Approaches to Barrier Dysfunction

    Frontiers in Nutrition, Vol. 8

  2. The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults

    Advances in Therapy, Vol. 38, Núm. 5, pp. 2054-2076

2020

  1. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  2. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Intestinal mucosal mast cells: Key modulators of barrier function and homeostasis

    Cells, Vol. 8, Núm. 2

2018

  1. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction

    Scientific Reports, Vol. 8, Núm. 1

  2. Epithelial immunity: Priming defensive responses in the intestinal mucosa

    American Journal of Physiology - Gastrointestinal and Liver Physiology

  3. Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis

    Clinical and Translational Gastroenterology, Vol. 9, Núm. 4

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

  3. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome

    Journal of Gastroenterology and Hepatology (Australia), Vol. 32, Núm. 1, pp. 53-63

2016

  1. Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis

    Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 78-91

2015

  1. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

    Gut, Vol. 64, Núm. 9, pp. 1379-1388